Despite concerns, FDA panel reverses course on ALS drug and recommends approval : Shots
The drugmaker Amylyx is asking the FDA to approve a brand new remedy for ALS,
drugs and supplement diarrhea
FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote – Consumer Health News
TUESDAY, Sept. 6, 2022 (HealthDay Information) – A U.S. Meals and Drug Administration panel will